Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan
Abstract
Authors
L. Lewis M. Taylor Y. Suriya N. Kuanysh S. Kaldygul A. Ramil